Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

‘Overlooked and Misunderstood’ Gene Linked to Schizophrenia

By University of Aberdeen | October 5, 2016

Scientists have discovered new evidence strengthening the link between a previously misunderstood gene and major mental illnesses such as schizophrenia, bipolar disorder, depression and autism.

The University of Aberdeen-led research, published in Scientific Reports, expands on an unexpected finding by the same team two years ago that linked a poorly-understood gene with mental health disorders.

The 2014 study looked at five major groups of patients and identified that a mutation of the gene ULK4 was found far more frequently in patients with schizophrenia. The same mutation was also found in some people with bipolar disorder, depression and autism.

Before this Aberdeen work, ULK4 had previously been associated with hypertension but never before with mental health disorders.

In this latest study in collaboration with Tongji University, Shanghai, the team used cutting-edge techniques to ‘turn off’ ULK4 in selected subsets of stem cells in the mouse brain. They then observed that the offspring of these stem cells turned up in the wrong places, become ‘lost’ and ‘communicated less’ with neighbouring nerve cells.

These problems were rectified fully when the ULK4 gene was ‘turned back on’.

They conclude that ULK4 plays an essential role in normal brain development and when defective, the risk of neurodevelopmental disorders such as schizophrenia is increased.

Schizophrenia is among the top 10 causes of human disability worldwide. The causes are highly variable with both genetic and environmental factors contributing to overall risk. Although the chances of inheriting the condition are estimated at between 60-80%, the genes responsible for causing the condition remain highly controversial. Identifying which genes are responsible for these diseases opens the way for the development of therapies to treat the symptoms of these conditions.

First author of the paper, Dr Bing Lang from the University’s Institute of Medical Sciences, said: “Schizophrenia and other mental health disorders are multi-faceted and it is extremely complicated to identify which genes, in combination with other environmental factors, contribute to people developing the condition.

“This latest study supports our highly novel findings that the ULK4 gene plays a role in normal brain development, and that a mutation in the gene contributes to the risk of several neurodevelopmental disorders.

“We hope that by fully understanding the roles of ULK4 in schizophrenia, this will pave the way for the development of new drugs to treat this devastating condition.”

Related Articles Read More >

How Prelude and QDX are using quantum chemistry to discover cancer treatments
US political drama is pushing life sciences talent toward Switzerland, Basel leader says
Thermo Fisher targets early-stage CGT bottlenecks with new Philadelphia hub
AUTOMA+ 2025 brings global pharma expertise to Austria
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.
RD 25 Power Index

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2025 R&D 100 Award Winners
    • 2025 Professional Award Winners
    • 2025 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • R&D Index
    • Subscribe
    • Video
    • Webinars
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE